Variants at the syntaxin-6 (STX6) locus have been identified by genome-wide association studies (GWAS) as shared genetic risk factors for sCJD [24] and the most common primary tauopathy, progressive supranuclear palsy (PSP) [9, 10, 15, 16, 19]. This evidence concerns the gene STX6 and progressive supranuclear palsy.